FilingSEC EDGAR6-K
Quantum BioPharma Announces Consolidation of Market Manipulation Lawsuits and Appointment of Lead Counsel
· SEC accepted
Stagelitigation
Filing content
The U.S. District Court consolidated Quantum BioPharma's market manipulation lawsuits and appointed Grant & Eisenhofer as lead counsel.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…